Modified Venous Excess Ultrasound (mVExUS) Grades and CA125 Levels in Acute Decompensated Heart Failure
Background and Objectives: Systemic venous congestion is a key feature of acute decompensated heart failure (ADHF). Carbohydrate antigen-125 (CA125) is a biomarker of congestion, whereas venous excess ultrasound provides a noninvasive assessment of systemic venous congestion. We evaluated the association between CA125 and congestion severity assessed by a modified venous excess ultrasound (mVExUS) protocol in patients hospitalized with ADHF. Materials and Methods: This single-center observational study included 112 consecutive patients with ADHF. mVExUS was based on inferior vena cava diameter and hepatic and portal venous Doppler patterns. mVExUS was evaluable in 108 patients, CA125 was available in 106, and 102 had both measurements. The full mVExUS spectrum was examined; grade 3 versus grades 0–2 was used for regression and discrimination analyses. Results: Median CA125 concentrations across mVExUS grades 0, 1, 2, and 3 were 63 (17–210), 61 (20–127), 48.5 (21.5–60), and 151 (88.8–331.8) U/mL, respectively (p < 0.001). Ordinal mVExUS grade correlated with CA125 (ρ = 0.42, p < 0.001). After adjustment for age, sex, eGFR, atrial fibrillation, and severe tricuspid regurgitation, ln (CA125) remained associated with mVExUS grade 3 (adjusted OR 2.73, 95% CI 1.56–4.77; p < 0.001). CA125 showed moderate discrimination for grade 3 congestion (AUC 0.790, 95% CI 0.704–0.873); a threshold of 73 U/mL yielded 80.4% sensitivity and 69.6% specificity. Grade 3 patients also had a longer hospital stay (11 (9–15) vs. 7 (6–12) days; p = 0.001). Conclusions: Higher CA125 levels were associated with severe mVExUS-defined systemic venous congestion. CA125 and mVExUS may provide complementary information, although the derived threshold requires external validation.
Authors
- İrem Müge Akbulut (ORCID: https://orcid.org/0000-0002-9190-0009)
- Gözde Cansu YILMAZ (ORCID: https://orcid.org/0000-0002-1929-6572)
- Tamer Sayın (ORCID: https://orcid.org/0000-0003-3716-540X)
- Volkan Kozluca (ORCID: https://orcid.org/0000-0002-4077-4364)
- Mehmet Emre Özerdem (ORCID: https://orcid.org/0000-0001-8153-5258)
- Nail Burak Özbeyaz (ORCID: https://orcid.org/0000-0002-7132-4286)
- Berke Turan Dogan (ORCID: https://orcid.org/0009-0006-4099-5008)
Institutions
- Ankara University (TR)
Publication Details
- Journal
- Medicina
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3390/medicina62112273
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00